» Articles » PMID: 28992829

Night-to-Night Sleep Variability in Older Adults With Chronic Insomnia: Mediators and Moderators in a Randomized Controlled Trial of Brief Behavioral Therapy (BBT-I)

Overview
Specialties Neurology
Psychiatry
Date 2017 Oct 11
PMID 28992829
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: Sleep variability is a clinically significant variable in understanding and treating insomnia in older adults. The current study examined changes in sleep variability in the course of brief behavioral therapy for insomnia (BBT-I) in older adults who had chronic insomnia. Additionally, the current study examined the mediating mechanisms underlying reductions of sleep variability and the moderating effects of baseline sleep variability on treatment responsiveness.

Methods: Sixty-two elderly participants were randomly assigned to either BBT-I or self-monitoring and attention control (SMAC). Sleep was assessed by sleep diaries and actigraphy from baseline to posttreatment and at 3-month follow-up. Mixed models were used to examine changes in sleep variability (within-person standard deviations of weekly sleep parameters) and the hypothesized mediation and moderation effects.

Results: Variabilities in sleep diary-assessed sleep onset latency (SOL) and actigraphy-assessed total sleep time (TST) significantly decreased in BBT-I compared to SMAC (Pseudo = .12, .27; = .018, .008). These effects were mediated by reductions in bedtime and wake time variability and time in bed. Significant time × group × baseline sleep variability interactions on sleep outcomes indicated that participants who had higher baseline sleep variability were more responsive to BBT-I; their actigraphy-assessed TST, SOL, and sleep efficiency improved to a greater degree (Pseudo = .15 to .66; < .001 to .044).

Conclusions: BBT-I is effective in reducing sleep variability in older adults who have chronic insomnia. Increased consistency in bedtime and wake time and decreased time in bed mediate reductions of sleep variability. Baseline sleep variability may serve as a marker of high treatment responsiveness to BBT-I.

Clinical Trial Registration: ClinicalTrials.gov, Identifier: NCT02967185.

Citing Articles

The impact of mindfulness training on posttraumatic stress disorder symptoms, subjective sleep quality, and objective sleep outcomes in police officers.

Imhoff-Smith T, Grupe D Psychol Trauma. 2023; .

PMID: 37650805 PMC: 10902185. DOI: 10.1037/tra0001566.


Recent Developments in the Management of Insomnia in Later Life.

Tighe C, Bramoweth A Curr Treat Options Psychiatry. 2023; 5:195-210.

PMID: 37560530 PMC: 10411142. DOI: 10.1007/s40501-018-0145-1.


Outcomes From the Transdiagnostic Sleep and Circadian Intervention (TranS-C) for Midlife and Older Adults With Serious Mental Illness and Sleep and Circadian Dysfunction.

Sarfan L, Gasperetti C, Gumport N, Harvey A Behav Ther. 2022; 53(4):585-599.

PMID: 35697424 PMC: 10927276. DOI: 10.1016/j.beth.2022.02.001.


The Impact of Cognitive Behavioral Therapy for Insomnia on Sleep Log and Actigraphy Outcomes in People with Multiple Sclerosis: A Secondary Analysis.

Williams-Cooke C, LeSuer L, Drerup M, Siengsukon C Nat Sci Sleep. 2021; 13:1865-1874.

PMID: 34675730 PMC: 8520446. DOI: 10.2147/NSS.S324879.


The Sleep Regularity Questionnaire: development and initial validation.

Dzierzewski J, Donovan E, Sabet S Sleep Med. 2021; 85:45-53.

PMID: 34274811 PMC: 8429093. DOI: 10.1016/j.sleep.2021.06.028.


References
1.
Irwin M, Cole J, Nicassio P . Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006; 25(1):3-14. DOI: 10.1037/0278-6133.25.1.3. View

2.
Vgontzas A, Fernandez-Mendoza J, Liao D, Bixler E . Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013; 17(4):241-54. PMC: 3672328. DOI: 10.1016/j.smrv.2012.09.005. View

3.
Sanchez-Ortuno M, Edinger J . Internight sleep variability: its clinical significance and responsiveness to treatment in primary and comorbid insomnia. J Sleep Res. 2012; 21(5):527-34. DOI: 10.1111/j.1365-2869.2012.01010.x. View

4.
Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R . Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006; 29(11):1391-7. DOI: 10.1093/sleep/29.11.1391. View

5.
MacKinnon D, Fairchild A, Fritz M . Mediation analysis. Annu Rev Psychol. 2006; 58:593-614. PMC: 2819368. DOI: 10.1146/annurev.psych.58.110405.085542. View